Craft
  • Home
  •  / 3T Biosciences
3T Biosciences

3T Biosciences

Total Funding

$12 M

3T Biosciences Summary

Company summary

Overview
3T Biosciences is an immunotherapy company. It develops therapies against cancer by combining experimental biology and artificial intelligence. The Company uses machine learning to predict what chemicals affect cancer cells and modifies T cells.
Type
Private
Founded
2017
HQ
South San Francisco, CA, US | view all locations
Website
https://www.3tbiosciences.com/
Cybersecurity rating
Sectors

Key people

  • Marvin Gee

    Marvin Gee, Co-Founder, Head of Target Discovery

    • John Connolly

      John Connolly, Interim CEO

      • Leah Sibener

        Leah Sibener, Co-Founder, Head of Therapeutic Discovery

        • Hanspeter Gerber

          Hanspeter Gerber, Chief Scientific Officer

          LocationsView all

          1 location detected

          • South San Francisco, CA HQ

            United States

            Building 84, 681 Gateway Blvd

          News

          Footer menu